Smith Graham & Co Investment Advisors’s LifePoint Health, Inc. LPNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-238,590
Closed -$11.6M 136
2018
Q2
$11.6M Sell
238,590
-720
-0.3% -$37.3K 1.1% 12
2018
Q1
$11.2M Buy
239,310
+33,530
+16% +$1.61M 1.08% 14
2017
Q4
$10.2M Buy
205,780
+86,130
+72% +$4.28M 0.96% 26
2017
Q3
$6.93M Sell
119,650
-1,220
-1% -$72.5K 0.73% 61
2017
Q2
$8.12M Sell
120,870
-6,520
-5% -$412K 0.88% 41
2017
Q1
$8.34M Sell
127,390
-2,310
-2% -$143K 0.89% 39
2016
Q4
$7.37M Buy
129,700
+12,420
+11% +$719K 0.8% 55
2016
Q3
$6.95M Buy
117,280
+3,370
+3% +$202K 0.88% 37
2016
Q2
$7.45M Sell
113,910
-7,310
-6% -$497K 1.03% 18
2016
Q1
$8.39M Buy
121,220
+4,300
+4% +$287K 1.1% 16
2015
Q4
$8.58M Sell
116,920
-3,310
-3% -$235K 1.22% 9
2015
Q3
$8.52M Sell
120,230
-380
-0.3% -$30.8K 1.24% 12
2015
Q2
$10.5M Sell
120,610
-1,350
-1% -$102K 1.41% 9
2015
Q1
$8.96M Sell
121,960
-140
-0.1% -$9.93K 1.21% 16
2014
Q4
$8.78M Sell
122,100
-7,520
-6% -$521K 1.25% 14
2014
Q3
$8.97M Sell
129,620
-3,590
-3% -$252K 1.32% 9
2014
Q2
$8.27M Sell
133,210
-5,400
-4% -$317K 1.15% 17
2014
Q1
$7.56M Sell
138,610
-9,740
-7% -$521K 1.09% 31
2013
Q4
$7.84M Sell
148,350
-492
-0.3% -$24.7K 1.11% 33
2013
Q3
$6.94M Sell
148,842
-1,410
-0.9% -$67.5K 1% 35
2013
Q2
$7.34M Buy
+150,252
New +$7.2M 1.13% 24

Other funds holding LPNT

Smith Graham & Co Investment Advisors's LPNT Position: Q3 2018 in Review

Smith Graham & Co Investment Advisors sold out of LifePoint Health, Inc. (LPNT) in Q3 2018, closing a stake of 238,590 shares — an estimated $11.6M sold.

Smith Graham & Co Investment Advisors first reported a position in LPNT in Q2 2013 and held it in 21 quarters. The position peaked at $11.6M in Q2 2018. 223 funds tracked by Wall St. Rank hold LPNT as of Q3 2018.

  • Smith Graham & Co Investment Advisors reported no remaining LifePoint Health, Inc. position as of Q3 2018 after selling out during the quarter.
  • Smith Graham & Co Investment Advisors sold 238,590 LifePoint Health, Inc. shares in Q3 2018, an estimated $11.6M.
  • Smith Graham & Co Investment Advisors first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 21 quarters.
  • Smith Graham & Co Investment Advisors's LifePoint Health, Inc. position peaked at $11.6M in Q2 2018.
  • 223 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q3 2018.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q3 2018, filed 29 Oct 2018.